GlassScriptPhysician profile
Daniel G Kean
NPI 1407866528
$1,739.38
in general payments reported to CMS, 2019-2025
16 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $61.49 · 2021: $116 · 2022: $320 · 2023: $292 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $553.85 | 2019-2025 | Relistor |
| Daiichi Sankyo INC. | $187.05 | 2019 | |
| Medtronic, INC. | $167.71 | 2022 | |
| Vertos Medical, INC. | $147.56 | 2023 | Mild Device Kit |
| Abiomed | $144.38 | 2023 | Impella |
| Mdd US Operations, LLC | $124.36 | 2019 | |
| Si-Bone, INC. | $110.66 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $54.55 | 2022 | |
| Pfizer INC. | $50.24 | 2019 | |
| Collegium Pharmaceutical, INC. | $44.64 | 2019 | |
| Tonix Medicines, INC. | $40.81 | 2025 | Tonmya |
| Biodelivery Sciences International, INC. | $37.17 | 2019 | |
| Shionogi INC | $29.09 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $17.65 | 2019 | |
| Medtronic USA, INC. | $15.49 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.